Yehuda Zisapel, Founder and President
Yehuda Zisapel holds an M.Sc. degree in Electronic Engineering from the Haifa Technion (Israel), an MBA from Tel-Aviv University (Israel), and Doctor Honoris Causa from the Technion (Israel). He is the founder and director of the RAD Group, a holding that comprises 22 high-tech companies in computer communication technologies, six of which are publicly held and traded on the NASDAQ, and the chairman of Rad-Ramot Biomedical incubator. He has served as President of Neurim Pharmaceuticals since it commenced active operations in 1992.

Nava Zisapel, Founder and Chief Scientific Officer
Nava Zisapel holds a B.Sc. in Chemistry, an M. Sc. in Biochemistry, and a Ph.D. in Biochemistry from Tel-Aviv University (Israel). She is a full professor at Tel-Aviv University with a specialization in Neuro-biochemistry and the incumbent of the Michael Gluck Chair in Neuropharmacology and ALS Research, USA. Nava Zisapel has authored with her students and collaborator scientists over 160 original research publications in peer-reviewed journals.

Talia Grossman, Chief Financial Officer
Talia is Certified Public Accountant in Israel and holds an MBA degree and a BA degree in Accountancy and Economics both from Tel-Aviv University. Talia joined Neurim in 2008 and serves as the company's chief financial officer and COO. Before joining the company she was the CFO & COO of another pharmaceuticals company and prior to that Talia served as the CFO and Vice President Finance & Operations of Yissum, the Technology Development & Licensing company of the Hebrew University in Jerusalem. In the past Talia worked as an investment banker and headed the Life Sciences desk at the Corporate Finance department in Tamir Fishman & Associates, Tel Aviv